Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.38 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.32 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.32 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.30 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.30 |
| ▸ | PRKDC | P78527 | 1/20 | 0.30 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17827465 | 1.00 | ALOX5 (0.38) | ALOX5GGPS1PLA2G2APLA2G4AESR1 | |
| SCHEMBL17827457 | 0.99 | ALOX5 (0.37) | ALOX5GGPS1PLA2G2APLA2G4AESR1 | |
| SCHEMBL18326149 | 0.96 | ALOX5 (0.38) | ALOX5GGPS1PLA2G2APLA2G4AESR1 | |
| SCHEMBL16858181 | 0.95 | ALOX5 (0.37) | ALOX5GGPS1PLA2G2APLA2G4A | |
| SCHEMBL17126341 | 0.95 | ALOX5 (0.38) | ALOX5GGPS1ESR1ESR2 | |
| SCHEMBL18326148 | 0.95 | ALOX5 (0.38) | ALOX5GGPS1ESR1ESR2 | |
| SCHEMBL17816766 | 0.94 | ALOX5 (0.37) | ALOX5GGPS1ESR1ESR2 | |
| SCHEMBL17804759 | 0.94 | ALOX5 (0.38) | ALOX5GGPS1PLA2G2APLA2G4AESR1 | |
| SCHEMBL22403507 | 0.93 | ALOX5 (0.36) | ALOX5GGPS1 | |
| SCHEMBL16996228 | 0.93 | ALOX5 (0.37) | ALOX5GGPS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9929355-B2 | Amine compound and organic electroluminescent device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-27 | — | — | US | disclosed |
| US-9929355-B2 | Amine compound and organic electroluminescent device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-27 | — | — | US | disclosed |
| US-20160172593-A1 | AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-06-16 | — | — | US | disclosed |
| US-20160172593-A1 | AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160172593-A1 | AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | AOC2, SAT1, ODC1 | ALOX5 1438/4885GGPS1 2764/4885PLA2G2A 3891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.